What Is Divalproex ER? Uses, Effects & Warnings

Divalproex ER is an extended-release tablet form of divalproex sodium, a medication used to treat epilepsy, bipolar disorder, and prevent migraines. Sold under the brand name Depakote ER, it delivers the same active ingredient as standard divalproex but is designed to be taken once a day instead of two or three times. The “ER” stands for extended release, meaning the drug is absorbed gradually over a longer period.

What Divalproex ER Treats

Divalproex ER has three FDA-approved uses. It treats complex partial seizures and absence seizures in people with epilepsy, either alone or alongside other seizure medications. It treats manic episodes in bipolar disorder, the periods of abnormally elevated mood, energy, and impulsive behavior. And it prevents migraine headaches, though it is not designed to stop a migraine once one has already started.

How It Works in the Brain

Divalproex works through several overlapping mechanisms that all reduce excessive electrical activity in the brain. It blocks sodium channels on nerve cells, which slows down the rapid-fire signaling that triggers seizures. It also increases levels of GABA, the brain’s main calming chemical, in two ways: it prevents the enzyme that normally breaks GABA down from doing its job, and it boosts the production of new GABA by enhancing the enzyme that converts the brain’s primary excitatory chemical (glutamate) into GABA. The net effect is a brain that is less prone to the runaway electrical storms behind seizures, the mood instability of bipolar disorder, and the neurological cascade that produces migraines.

How ER Differs From Standard Divalproex

Standard divalproex (sometimes labeled “DR” for delayed release) is typically taken two or three times a day. The extended-release version delivers the same total drug exposure over 24 hours but with a single daily dose. In FDA pharmacokinetic studies, the ER formulation produced lower peak blood concentrations than the DR version. In one study of epilepsy patients, peak levels averaged about 83 mcg/mL with ER compared to roughly 93 mcg/mL with standard dosing.

That flatter drug curve matters in practice. Lower peaks can mean fewer side effects that are tied to high blood concentrations, like tremor and drowsiness. To compensate for the slower absorption, ER doses are typically 8 to 20% higher than the equivalent standard dose. So if you were taking 875 mg of standard divalproex per day, the ER equivalent would be about 1,000 mg.

Common Side Effects

The most frequently reported side effects depend on the condition being treated and the dose, but some patterns are consistent across uses.

Tremor is the most recognizable side effect. In epilepsy trials using higher doses, 57% of patients experienced tremor compared to 19% on lower doses. For migraine prevention, which uses lower doses overall, tremor affected about 9% of patients versus none on placebo.

Hair thinning (alopecia) is another commonly reported concern. It showed up in 24% of epilepsy patients on high-dose therapy and about 7% of those taking it for migraines. Weight gain occurs as well, affecting roughly 8 to 9% of patients across indications compared to 2 to 4% on placebo. Other common effects include nausea, drowsiness, dizziness, and digestive upset, particularly when first starting the medication.

Serious Safety Warnings

Divalproex carries three boxed warnings, the most serious category of safety alert the FDA issues.

Liver Damage

Fatal liver failure has occurred in patients taking divalproex and related drugs. Children under two years old face the highest risk, particularly those taking multiple seizure medications or those with underlying metabolic or brain disorders. Most cases of severe liver injury have appeared within the first six months of treatment. Early warning signs include unusual tiredness, weakness, facial swelling, loss of appetite, and vomiting.

Pancreatitis

Life-threatening inflammation of the pancreas has been reported in both children and adults. Some cases progressed rapidly from first symptoms to death. This risk exists whether you have been on the medication for days or years. Abdominal pain, nausea, vomiting, and loss of appetite are the warning signs that need immediate medical attention.

Pregnancy Risks

This is one of the most significant concerns with divalproex. The drug causes serious birth defects, particularly neural tube defects like spina bifida. In the general population, the risk of neural tube defects is about 0.14 to 0.2%. For women taking divalproex, that risk jumps to 1 to 2%. A North American pregnancy registry found congenital malformations in 10.7% of infants exposed to divalproex during the first trimester, a four-fold increase compared to other seizure medications.

The risks go beyond structural birth defects. A large study published in JAMA Network Open found that children exposed to divalproex before birth had roughly 4.5 times the risk of intellectual disability compared to unexposed children, and about 6 times the risk when intellectual disability was combined with delayed developmental milestones. Prenatal exposure has also been linked to higher rates of attention-deficit/hyperactivity disorder, autism, and impaired academic performance. These cognitive effects persisted even after researchers excluded children who had physical birth defects, suggesting the drug affects brain development independently.

Blood Level Monitoring

Doctors typically monitor blood levels of divalproex to ensure the dose is effective without being excessive. The generally accepted therapeutic range is 50 to 100 mcg/mL. Blood draws are usually done as “trough” levels, meaning the sample is taken right before your next dose when the drug is at its lowest concentration. If seizures or mood episodes aren’t well controlled and your blood level is below 50, there is usually room to increase the dose. Levels consistently above 100 raise the risk of side effects and toxicity.

Liver function tests and complete blood counts are also part of routine monitoring, particularly in the first six months when the risk of liver problems is highest. Your doctor will likely check these before starting the medication and at regular intervals afterward.

How to Take Divalproex ER

The tablet should be swallowed whole, not crushed, split, or chewed. Breaking the tablet destroys the extended-release mechanism and can cause the entire dose to be absorbed at once. It is typically taken once daily, and taking it with food can reduce stomach upset. Starting doses vary by condition: for epilepsy, initial dosing is based on body weight at 10 to 15 mg per kilogram per day. For migraine prevention, the usual starting point is 500 mg once daily, with a maximum of 1,000 mg per day. For bipolar mania, the starting dose is 750 mg daily. In all cases, doses are gradually increased over weeks until symptoms are controlled or side effects become limiting.

If you are switching from the standard twice- or three-times-daily version to the ER tablet, the ER dose will be slightly higher to account for the difference in absorption. The total daily amount of drug your body receives remains equivalent.